期刊
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
卷 12, 期 9, 页码 1025-1044出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/187152012803529664
关键词
15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)); Anti-cancer agents; Apoptosis; Breast cancer; Cell cycle arrest; Differentiation; Estrogen Receptors (ERs); Fatty acids; Growth inhibition; Ligands; Methylene-substituted diindolylmetyhanes (CDIMs); Oncogenesis; Peroxisome Proliferator-Activated Receptor-gamma (PPAR gamma); Prognostic value; Retinoid-X-Receptor (RXR); Statins; Thiazolidinediones (TZDs)
Peroxisome Proliferator-Activated Receptor-gamma (PPAR gamma) is an extensively studied ligand-activated nuclear hormone receptor that functions as transcription factor and plays an important role in diverse biological processes, such as lipid metabolism and insulin sensitization. Recent studies have demonstrated that PPAR gamma is over-expressed in many tumor types, including breast cancer, suggesting a possible role in tumor development and/or progression and a putative prognostic value. Moreover, naturally-occurring and synthetic PPAR gamma agonists promote growth inhibition, apoptosis and differentiation of tumor cells. The present review summarizes the available information on PPAR gamma expression in breast tumors and the use of PPAR gamma ligands as anti-cancer agents for breast cancer treatment, both in vitro and in vivo. Considering the data so far, specific PPAR gamma agonists seem to exert beneficial effects against breast cancer and may therefore represent potential therapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据